Technology

MOAJ Holding invests $30M in Joint Venture with MediSun Energy to Tackle Water Scarcity and Brine Challenges in Saudi Arabia

Published

2 years ago

September 30, 2024

SINGAPORE, Sept. 30, 2024 /PRNewswire/ — MediSun Energy and MOAJ Holding are pleased to announce the formation of MediSun Arabia, a joint venture designed to drive innovative energy solutions and tackle water scarcity in Saudi Arabia. As part of this strategic partnership, MOAJ Holding will invest USD 30 million to establish a cutting-edge manufacturing facility and co-develop a Saudi Brine Management Program with MediSun Energy.

The venture will include the construction of a manufacturing hub to produce MediSun’s WEGen stacks, critical components supporting renewable energy projects across the region. This facility will boost local industrial capabilities and play a central role in Saudi Arabia’s renewable energy transition, aligning with Saudi Vision 2030. Additionally, MOAJ Holding will be the exclusive distributor of MediSun Energy’s technologies throughout the Gulf Cooperation Council (GCC), expanding MediSun’s footprint in the Middle East.

Together, the partners will spearhead the Saudi Brine Management Program in collaboration with a leading academic institution renowned for its desalination research. This ambitious R&D initiative aims to address the environmental challenges of desalination brine by developing cutting-edge treatment technologies aligned with Saudi Arabia’s sustainability goals.

Dusun Kim, CEO of MediSun Energy, commented, “This joint venture marks a significant milestone for MediSun Energy as we expand operations in Saudi Arabia. Our WEGen technology, which harnesses Reverse Electrodialysis (RED) to efficiently convert saltwater into electricity, will play a key role in advancing Saudi Arabia’s sustainability targets by generating clean energy and reducing consumption. With MOAJ as our partner in the GCC, we look forward to a long-term partnership that drives meaningful impact.”

HE Mohammed N. Al Jasser, Founder of MOAJ Holding, added, “We are excited to partner with MediSun Energy in this transformative joint venture. Our shared vision for advancing sustainable energy and water management in Saudi Arabia highlights the significance of this collaboration. MediSun’s WEGen technology, which enhances energy efficiency while producing clean power, is aligned with the region’s sustainability goals. Together, we are dedicated to delivering these innovative solutions to the broader Middle East market.”

This joint venture positions both MOAJ and MediSun as key players in addressing the region’s water and energy challenges, aligned with Saudi Arabia’s Vision 2030 for a sustainable future.

About MediSun Energy

MediSun Energy is a technology-driven company focused on providing innovative, clean energy solutions. Its flagship WEGen technology leverages osmotic power to enhance energy efficiency in water desalination and renewable energy generation. Committed to a net-carbon neutral future, MediSun delivers sustainable, practical solutions that align with the global vision for a greener planet.

About MOAJ Holding

MOAJ Holding is a leading investment group with a focus on sustainable development across key sectors including energy, technology, and infrastructure. In line with Saudi Arabia’s Vision 2030, MOAJ invests in transformative projects that promote economic diversification and environmental sustainability.

For more information, visit www.medisun.energy or write to info@medisun.energy. You can also follow MediSun on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/moaj-holding-invests-30m-in-joint-venture-with-medisun-energy-to-tackle-water-scarcity-and-brine-challenges-in-saudi-arabia-302260006.html

SOURCE MediSun Energy

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

49 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

49 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

49 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated